Skip to main content

Raise Your Profile

Whether you are looking to attract a new business client, investment and partnering deal flow or talent, among other goals, One Nucleus offers a wide range of opportunities to raise your profile to our members and to the Greater Cambridge cluster in particular.
Raise Your Profile
  • Discounts for Members

    Discounts for Members

    Members can take advantage of discounts on a wide range of products and services to maximise their return on the member subscription, often recovering multiples of the fees paid. Receive discounted rates on laboratory supplies, services, key industry events and more.
    Learn more
  • Connect with Our Network

    Connect with Our Network

    A key advantage to any company joining One Nucleus is the ability to connect to potential partners, investors, service providers, clients and their peers for knowledge-sharing. We do this through our varied range of informative networking events, which tend to be situated throughout Cambridge and London.
    Learn more
  • Build the Best Teams

    Build the Best Teams

    One Nucleus recognises that a company’s employees are its most valuable asset and the competition for talented and skilled employees has never been fiercer in the region’s life science sector. One Nucleus offers a range of services and engagement opportunities in this critical area to help support our members.
    Learn more

Events

Connecting and meeting with business partners, fellow innovators and key advisers is a vital part of everyone's endeavours since it enables knowledge exchange and onward contact for mutual and collective success. Complementing the wider One Nucleus support activities our portfolio of events is designed to meet the needs of our network in terms of content, format, timing, peer-to-peer engagements and modes of delivery.
  • Events
  • Events
  • Events
  • Events

Membership Overview

With Gold and Silver membership options, our 400 company members and their staff can benefit from a wide variety of savings, profiling opportunities, and more.
  • Membership

About One Nucleus

One Nucleus is a not-for-profit Life Sciences & Healthcare membership organisation headquartered in Cambridge. We support institutions, companies and individuals in the Life Sciences sector providing local, UK-wide and international connectivity. 
  • About

UK Budget an Opportunity for Government to Lay Out Clear ‘NHS Investment Strategy’

  • Government’s ambitions to solve NHS crisis lack sufficient detail.
  • Collaboration with private sector and life sciences is crucial to tackle NHS backlog and provide much needed investment.
  • Tax and fiscal incentives important to encourage investment in the sector.
  • Regulation and procurement barriers must be tackled if innovative solutions are to feed through to the NHS.

15 October 2024

Overcoming Pharmaceutical and Other Materials Issues Before They Exist. Two New Scientific Papers on the Conclusions of the 7th Crystal Structure Prediction Blind Test

Cambridge, UK – 16 October 2024 – The Cambridge Crystallographic Data Centre (CCDC) announces two significant scientific papers detailing the findings of the 7th Crystal Structure Prediction (CSP) Blind Test. To coincide with the publication of the two papers, the CCDC has released a CSP Blind Test database that contains 171,679 entries from 207 landscapes.

Expanding CSP Beyond Pharmaceuticals

Dexcom vs Abbott at the UPC

Glucose sensing and continuous glucose monitoring (CGM) manufacturer for diabetes management, Dexcom, and pharmaceutical and medical devices organisation, Abbott, have been locked in a series of patent disputes over their continuous glucose monitoring (CGM) devices and systems, in a battle that spans multiple patents and several jurisdictions including the UK, US and Germany. In the UK alone, both parties have brough infringement proceedings, with a total of seventeen patents being at issue.

Malaria: New Vaccines Hailed as a Breakthrough in the Fight Against the Disease

In January 2024 Cameroon launched the world’s first routine malaria vaccine programme. By incorporating the RTS,S vaccine into its standard immunisation schedule, Cameroon aims to protect thousands of children across Africa and significantly reduce malaria-related fatalities.

Closely following suit, the Côte d’Ivoire has recently become the first country to roll-out the new R21/Matrix-M™ vaccine, in another key advancement in the battle against malaria.

Visual Branding: Crafting Consistency for Business Growth

Visual branding. We all know it's crucial. Some of us think we have it down. But are we confident our branding is truly driving growth?

Join us for a 1.5-hour workshop with Krishna Solanki.

Krishna will share insights from her extensive experience creating visual brand identities, covering what makes a strong visual identity, why consistency matters, and how to maintain it across all platforms.

Subscribe to